Related by context. All words. (Click for frequent words.) 74 docetaxel 73 paclitaxel 72 5 fluorouracil 72 5FU 71 irinotecan 71 gemcitabine 70 fluorouracil 70 doxorubicin 70 temozolomide 69 dacarbazine 69 rituximab 69 topotecan 69 cisplatin 69 leucovorin 69 oxaliplatin 69 chemotherapies 68 chemotherapeutic agents 68 trastuzumab 68 chemotherapeutic agent 68 etoposide 67 Fludara 67 bortezomib 67 docetaxel chemotherapy 67 bevacizumab 67 Cisplatin 67 carboplatin 67 erlotinib 67 cytarabine 66 Irinotecan 66 vinorelbine 66 FOLFIRI 66 pegylated liposomal doxorubicin 66 mitoxantrone 66 docetaxel Taxotere 66 carboplatin paclitaxel 66 chemotherapy regimens 65 Taxotere ® 65 VIDAZA 65 pemetrexed 65 cetuximab 65 chemotherapeutic drug 65 taxane 65 dasatinib 65 cyclophosphamide 65 sunitinib 64 5-FU/LV 64 epirubicin 64 sorafenib Nexavar 64 idarubicin 64 FOLFOX4 64 paclitaxel Taxol 64 decitabine 64 azacitidine 64 mycophenolate mofetil 64 Gemcitabine 64 mitomycin 64 trabectedin 64 erlotinib Tarceva ® 64 imatinib 64 gemcitabine chemotherapy 64 standard chemotherapy regimen 64 Taxotere 63 chlorambucil 63 docetaxel Taxotere ® 63 neurologic progression 63 TACE 63 fluoropyrimidine 63 5 Fluorouracil 63 vorinostat 63 estramustine 63 L asparaginase 63 Doxorubicin 63 Pemetrexed 63 lapatinib 63 pegfilgrastim 63 DOXIL 63 melphalan prednisone 63 CHOP chemotherapy 63 bendamustine 63 capecitabine 63 Bortezomib 63 chemotherapy docetaxel 63 Taxotere R 63 FOLFOX 62 temsirolimus 62 gemcitabine Gemzar 62 fulvestrant 62 fludarabine 62 Doxil 62 bevacizumab Avastin 62 tacrolimus 62 vincristine 62 Taxotere docetaxel 62 Fludarabine 62 chemotherapeutics 62 liposomal doxorubicin 62 Gefitinib 62 paclitaxel chemotherapy 62 Temozolomide 62 zoledronic acid 62 vandetanib 62 relapsed ovarian cancer 62 chemoradiation 62 adjuvant therapy 62 Bevacizumab 62 docetaxel Taxotere R 62 sorafenib 62 G CSF 62 CoFactor 62 gemcitabine carboplatin 62 alkylating agent 62 nab paclitaxel 62 Erlotinib 62 metastatic renal cell carcinoma 62 adriamycin 62 idraparinux 61 abiraterone acetate 61 axitinib 61 monotherapy 61 HER2 positive metastatic breast 61 methotrexate 61 gefitinib 61 interferon alfa 61 active metabolite 61 cytotoxic chemotherapy 61 low dose cytarabine 61 chemotherapy regimen 61 antitumor activity 61 dexamethasone 61 VAPRISOL 61 milatuzumab 61 Lenalidomide 61 Platinol 61 melphalan 61 amphotericin B 61 dose dexamethasone 61 imatinib Gleevec 61 interferon alpha 61 interferon 61 Hycamtin 61 Carboplatin 61 thalidomide Thalomid 61 paclitaxel Taxol ® 61 free survival PFS 61 posaconazole 61 plus dexamethasone 61 bleomycin 61 Dasatinib 61 administered subcutaneously 61 therapeutic regimens 61 Oxaliplatin 61 irinotecan chemotherapy 61 cyclophosphamide methotrexate 61 tyrosine kinase inhibitor 61 daunorubicin 61 Taxol ® 61 VELCADE 61 imetelstat 61 Torisel 61 gemcitabine cisplatin 61 taxanes 61 lapatinib Tykerb 60 chemoradiotherapy 60 cyclophosphamide Cytoxan 60 Xeloda 60 Targretin 60 Neulasta ® 60 Trastuzumab 60 CANCIDAS 60 Cyclophosphamide 60 MGd 60 Xeloda capecitabine 60 interferon alfa 2a 60 pertuzumab 60 panitumumab 60 administered intravenously 60 YONDELIS 60 IFN beta 60 pegylated interferon alfa 60 Fluorouracil 60 Doxil ® 60 cytotoxic 60 cisplatin chemotherapy 60 oblimersen 60 IFN alpha 60 ritonavir boosted 60 chemotherapeutic regimens 60 TNF inhibitor 60 neoadjuvant therapy 60 chemotherapy gemcitabine 60 cilengitide 60 xenograft models 60 DMARDs 60 5 FU leucovorin 60 PegIFN RBV 60 EGFR TKI 60 irbesartan 60 XELOX 60 taxane chemotherapy 60 TKIs 60 Capecitabine 60 ribavirin RBV 60 Camptosar ® 60 Peg IFN 60 Cremophor 60 goserelin 60 ceftriaxone 60 synthase TS 60 cytotoxic agents 60 chemotherapeutic regimen 60 N acetylcysteine 60 fibrinolytic 60 peginterferon alfa 2a 60 Amrubicin 59 BAY #-# 59 sirolimus 59 bevacizumab Avastin ® 59 Velcade bortezomib 59 peginterferon 59 Navelbine 59 dasatinib Sprycel 59 cediranib 59 bupivacaine 59 immunosuppressant 59 azacytidine 59 myelosuppressive 59 EGFr 59 metastatic colorectal cancer 59 Gliadel Wafer 59 adecatumumab 59 telaprevir dosed 59 overlapping toxicities 59 TAXOTERE R 59 chemotherapeutic drugs 59 subcutaneous SC 59 gefitinib Iressa 59 fondaparinux 59 dexamethasone Decadron 59 everolimus 59 EFAPROXYN 59 neoadjuvant chemotherapy 59 standard chemotherapy regimens 59 cetuximab Erbitux ® 59 FUSILEV enhances 59 bortezomib Velcade 59 Platinol ® cisplatin 59 Paclitaxel 59 Gemzar ® 59 trans retinoic acid ATRA 59 sunitinib malate 59 boosted protease inhibitor 59 CA4P 59 chemotherapeutic 59 imatinib therapy 59 dasatinib Sprycel ® 59 anthracycline 59 dose cytarabine 59 biologic therapy 59 concurrent chemoradiation 59 alkylating agents 59 TORISEL 59 paclitaxel carboplatin 59 protease inhibitor 59 infusional 5-FU/LV 59 intravenously administered 59 Etoposide 59 anti angiogenic agent 59 eniluracil 59 CIMZIA TM 59 DMARD 59 APTIVUS r 59 erlotinib Tarceva 59 CsA 59 corticosteroid dexamethasone 59 radiotherapy RT 59 Interferon alpha 59 intravesical 59 plus gemcitabine 59 imatinib mesylate 59 Imatinib 59 Natalizumab 59 amrubicin 59 FOLFOX6 59 intravenous bisphosphonates 59 nilotinib 59 sorafenib Nexavar ® 59 Zoledronic acid 59 LMWH 59 pegylated interferon 59 Seliciclib 58 Cytoxan 58 Xcytrin 58 xanthine oxidase inhibitor 58 subcutaneously administered 58 FOLFOX regimen 58 VELCADE melphalan 58 Interferon alfa 58 Cetuximab 58 Docetaxel 58 clodronate 58 cidofovir 58 anti CD3 58 Erbitux cetuximab 58 angiogenesis inhibitor 58 uric acid lowering 58 imipenem 58 Halaven 58 microtubule inhibitor 58 cinacalcet 58 interferon beta 58 Topotecan 58 anti leukemic 58 tegafur 58 external beam radiotherapy 58 relapsing multiple sclerosis 58 bevacizumab Avastin R 58 relapsed refractory 58 FOLFIRI alone 58 tyrosine kinase inhibitor TKI 58 CD# antibody [001] 58 gemcitabine Gemzar ® 58 rFVIII 58 unfractionated heparin 58 clopidogrel 58 azathioprine 58 mitomycin C 58 nucleoside analogs 58 trastuzumab Herceptin ® 58 arsenic trioxide 58 Vidaza azacitidine 58 imatinib Gleevec ® 58 Imprime PGG 58 ELOXATIN 58 mapatumumab 58 tiotropium bromide 58 recombinant erythropoietin 58 trastuzumab Herceptin R 58 humanized anti 58 AZT zidovudine Retrovir 58 MabCampath 58 octreotide LAR 58 Chemophase 58 progression TTP 58 pegylated 58 IMGN# 58 mRCC 58 piperacillin tazobactam 58 doxorubicin cyclophosphamide 58 sipuleucel T 58 Abraxane 58 ramipril 58 enzastaurin 58 T#I [002] 58 pomalidomide 58 Genasense 58 Temsirolimus 58 camptothecin 58 nucleoside analog 58 paclitaxel Taxol R 58 relapsed CLL 58 tamoxifen Nolvadex ® 58 timolol 58 adjuvant chemotherapy 58 oxaliplatin Eloxatin 58 cytotoxicity 58 lenalidomide dexamethasone 58 Cytarabine 58 budesonide 58 vinca alkaloids 58 Avastin bevacizumab 58 advanced NSCLC 58 Vidofludimus 58 fluvastatin 58 Epirubicin 58 gastrointestinal stromal tumors GIST 58 amprenavir 58 Neoadjuvant 58 calcitriol 58 tipranavir 58 relapsed MM 58 epoetin alfa 58 steroid dexamethasone 58 cetuximab Erbitux R 58 chemotherapy cisplatin 58 #beta estradiol 58 Arixtra 58 imatinib resistant 58 Fulvestrant 58 voriconazole 58 lenalidomide 58 comparator arm 58 recurrent GBM 58 pegylated interferon alpha 58 anthracyclines 58 granisetron 57 fenofibric acid 57 Platinol ® 57 CIMZIA ™ 57 trans retinoic acid 57 mesalamine 57 PEGPH# 57 allopurinol 57 superficial bladder cancer 57 TREANDA 57 sunitinib Sutent 57 untreated multiple myeloma 57 pyrazinamide 57 Omacetaxine mepesuccinate 57 mTOR inhibitors 57 tolerability 57 pharmacokinetic properties 57 Xanafide 57 direct thrombin inhibitor 57 peg IFN 57 rituximab Rituxan 57 calcineurin inhibitors 57 dacarbazine DTIC 57 verteporfin 57 interferon alfa 2b 57 etanercept 57 vancomycin 57 Ceplene/IL-2 57 oral clodronate 57 taxane therapy 57 TEMODAL 57 Tamibarotene 57 doxorubicin docetaxel 57 EBRT 57 PegIFN 57 Vidaza 57 vinca alkaloid 57 multikinase inhibitor 57 TMC# [001] 57 plasma uric acid 57 ELACYT 57 target enzyme thymidylate 57 immunomodulatory therapy 57 chemotherapy FOLFOX 57 bortezomib Velcade R 57 Gleevec resistant 57 nilotinib Tasigna ® 57 metastatic malignant 57 cyclophosphamide chemotherapy 57 cisplatin carboplatin 57 plus ribavirin 57 solid tumors 57 tolerability profile 57 taxol 57 Vfend 57 Pegasys ® 57 relapsed multiple myeloma 57 Cloretazine 57 ARIKACE 57 teriflunomide 57 dosing regimens 57 trastuzumab Herceptin 57 meropenem 57 octreotide 57 salmeterol fluticasone 57 intermittent dosing 57 HDACi 57 ISTODAX 57 OPAXIO 57 AKT inhibitor 57 PREZISTA r 57 ZOLINZA 57 amlodipine 57 nucleoside analogue 57 Paraplatin ® 57 metastatic castration resistant 57 cisplatin vinorelbine 57 subcutaneous formulation 57 Ribavirin 57 Paraplatin ® carboplatin 57 raltegravir 57 dalteparin 57 Fludara ® 57 GvHD 57 radiochemotherapy 57 liposomal formulation 57 ibandronate 57 PSMA ADC 57 palifosfamide 57 ixabepilone 57 molecularly targeted 57 Panzem R NCD 57 PEGylated Fab fragment 57 pamidronate 57 carvedilol 57 paclitaxel poliglumex 57 GRN#L 57 depsipeptide 57 pharmacologically active isomer 57 IRESSA 57 immunotherapy 57 rFVIIa 57 platelet inhibitor 57 adjuvant 57 isoproterenol 57 letrozole Femara 57 Rituxan 57 NRTIs 57 plus prednisone 57 dose escalation 57 alfa 2a 57 paricalcitol 57 Losartan 57 eribulin 57 intravenous cyclophosphamide 57 rituximab Rituxan ® 57 subcutaneously injected 57 Vidaza ® 57 Folfox 57 MabThera 57 CAELYX 57 SCCHN 57 busulfan 57 metastatic CRC 57 anticancer agent 56 APTIVUS 56 Rituxan rituximab 56 refractory NSCLC 56 temozolomide TMZ 56 DOXIL ® 56 pegylated interferon alfa 2a 56 fosamprenavir 56 PXD# 56 ganciclovir 56 Raltegravir 56 peginterferon alfa 2b 56 vincristine doxorubicin 56 levofloxacin 56 factor Xa 56 anti androgen 56 Vaprisol 56 TAXOTERE ® 56 nitazoxanide 56 Alkeran 56 Marqibo 56 Tarceva erlotinib 56 liver metastases 56 Hycamtin ® 56 brain metastases 56 levosimendan 56 anti angiogenic agents 56 anticancer agents 56 interferon therapy 56 CLORETAZINE TM VNP#M 56 Omacetaxine 56 protease inhibitors 56 pharmacokinetic profile 56 zalutumumab 56 hA# 56 Leucovorin 56 drug zotarolimus 56 Bleomycin 56 Pegylated Interferon 56 Pertuzumab 56 RLY# 56 oral deforolimus 56 Taxotere chemotherapy 56 mCRC patients 56 hepatic metastases 56 surrogate endpoint 56 Nilotinib 56 plus prednisone prednisolone 56 alpha interferon 56 PKC# 56 rt PA 56 anastrozole 56 Taxol paclitaxel 56 abiraterone 56 4mg/kg 56 nelfinavir 56 antiangiogenic 56 intravenous dosing 56 deferoxamine 56 dosage regimens 56 treprostinil 56 lopinavir r 56 protease inhibitor PI 56 pegylated interferons 56 cyclosporin 56 chemoradiation therapy 56 Jevtana 56 mertansine 56 neratinib 56 visilizumab 56 IRX 2 56 tenofovir Viread 56 IFN α 56 interferon IFN 56 methotrexate therapy 56 FOLFOX chemotherapy 56 OncoVEX GM CSF 56 betamethasone dipropionate 56 malignant pleural mesothelioma 56 recurrent glioblastoma multiforme 56 SUTENT 56 INTELENCE 56 epoprostenol 56 amifostine 56 tenecteplase 56 Orally administered 56 FluCAM 56 oral anticoagulant 56 pharmacodynamic PD 56 leukemia CLL 56 ancrod 56 ritonavir 56 dose regimens 56 Treanda 56 rhEPO 56 Camptosar ® irinotecan 56 #mg/m# [001] 56 veltuzumab 56 rifampicin 56 indolent NHL 56 Herceptin trastuzumab 56 Hizentra 56 glatiramer acetate 56 miconazole 56 PREZISTA rtv 56 CLL cells 56 seliciclib 56 tocilizumab 56 Pegasys peginterferon alfa 2a 56 Bezielle 56 capecitabine Xeloda 56 Azedra 56 alpha interferons 56 factor G CSF 56 TTF Therapy 56 huN# DM1 56 Neupogen ® 56 taxotere 56 sunitinib Sutent ® 56 dextran 56 glargine 56 entinostat 56 strontium ranelate 56 pazopanib 56 μg ml 56 FTY# 56 streptokinase 56 lanthanum carbonate 56 anticancer therapy 56 bolus dose 56 sirolimus eluting stents 56 glufosfamide 56 Tarceva 56 Alocrest 56 Melphalan 56 beclomethasone dipropionate 56 eplerenone 56 cisplatin gemcitabine 56 tiotropium 56 LEP ETU 56 GnRH agonists 56 esomeprazole 56 iniparib 56 TNFa 56 indinavir 56 Vorinostat 56 HSP# inhibitor 56 clopidogrel Plavix 56 Combination therapy 56 EGFR tyrosine kinase inhibitors 56 MIRCERA 56 PRT# 56 phosphate binders 56 Methotrexate 56 potentially hepatotoxic 56 infusional 56 Trabectedin 56 DAPT 56 receptor tyrosine kinase inhibitor 56 chronic lymphocytic leukemia CLL 56 ONCASPAR 56 heavily pretreated patients 56 Campath alemtuzumab 56 lenalidomide Revlimid R 56 LY# [002] 55 chemotherapy 55 prodrug 55 Mitoxantrone 55 AQ4N 55 HGS# 55 mg m² 55 complete remissions 55 factor Xa inhibitor 55 Toxicities 55 topoisomerase II inhibitor 55 antiretroviral regimen 55 ULORIC 55 aliskiren 55 XmAb# 55 T DM1 55 #mg/m# [002] 55 ara C 55 EGFR TKIs 55 durable remissions 55 mTOR inhibitor 55 eptifibatide 55 alteplase 55 Rituximab 55 ximelagatran 55 median PFS 55 fluconazole 55 Gleevec imatinib 55 KRAS mutations occur 55 dexrazoxane 55 EGF receptor 55 irinotecan doxorubicin oxaliplatin paclitaxel 55 anti angiogenic 55 GP IIb IIIa inhibitors 55 oral Hycamtin 55 CBLC# 55 Tarceva TM 55 Peginterferon 55 Aliskiren 55 low dose dexamethasone 55 polyethylene glycol PEG 55 OMP #M# 55 zoledronate 55 bicalutamide 55 metastatic GIST 55 Xelox 55 bone metastases 55 sirolimus eluting stent 55 cabazitaxel 55 tacrolimus ointment 55 Vinorelbine 55 Avastin 55 heavily pretreated 55 deferasirox 55 lamivudine 55 complete cytogenetic response 55 adalimumab Humira 55 HGS ETR2 55 gadobutrol 55 BEACOPP 55 nephrotoxicity 55 ABRAXANE ® 55 IV bisphosphonates 55 plasma kallikrein inhibitor 55 metaglidasen 55 capecitabine Xeloda R 55 lopinavir 55 colorectal cancer liver metastases 55 intradermal injection 55 transgene expression 55 pegylated interferon peg IFN 55 KRAS status 55 epirubicin cyclophosphamide 55 mycophenolate mofetil MMF 55 filgrastim 55 Allovectin 7 ® 55 Copegus ribavirin 55 Laquinimod 55 YERVOY 55 CDK inhibitor 55 VFEND 55 PegIntron 55 Epoetin alfa 55 gastrin 55 FOLPI 55 RECOTHROM 55 LEXIVA r 55 antiangiogenic therapy 55 adefovir 55 leukemia AML 55 Targretin capsules 55 tinidazole 55 antibody fragment 55 HCTZ 55 anticancer treatments 55 Elitek 55 Everolimus 55 iodixanol 55 Annexin V 55 locoregional recurrence 55 MyVax R 55 KAPIDEX 55 darunavir r 55 Proleukin 55 immunosuppressant drug 55 luteinizing hormone releasing 55 demonstrated antitumor activity 55 alefacept 55 DMARDS 55 MetMAb 55 PEGylated 55 TNFerade 55 tigecycline 55 RG# [001] 55 nucleoside reverse transcriptase inhibitor 55 Aflibercept 55 DAVANAT 55 aspirin heparin 55 ARB telmisartan 55 ZYVOX 55 infliximab 55 SPRYCEL 55 tenofovir emtricitabine 55 abacavir lamivudine 55 gel formulation 55 IFN alfa 55 Degarelix 55 rFIXFc 55 cyclophosphamide doxorubicin vincristine 55 nicardipine 55 recurrent NSCLC 55 INTEGRILIN R 55 colorectal liver metastases 55 vinorelbine tartrate 55 orally bioavailable 55 Navelbine ® 55 eribulin mesylate 55 tobramycin 55 virologic response 55 HuMax EGFr 55 tyrosine kinase inhibitors 55 Free Survival PFS 55 oral antiviral 55 Sorafenib 55 LY# [003] 55 plasmin 55 interferon α 55 galiximab 55 Nexavar 55 Bendamustine 55 NOXAFIL 55 somatostatin analogues 55 intravesical instillation 55 NNRTI 55 REVLIMID 55 radiofrequency ablation RFA 55 leflunomide 55 ZD# [001] 55 metformin 55 TYKERB 55 proton pump inhibitor 55 Annamycin 55 cytostatic 55 dose cohorts 55 ethambutol 55 tolvaptan 55 Vivaglobin 55 FIRMAGON 55 TNF antagonist 55 moxifloxacin 55 humanised monoclonal antibody 55 Sanofi Aventis Taxotere 55 partial remissions 55 rHuPH# 55 lytic 55 ribavirin 55 Flu Cy 55 IAP inhibitor 55 hematologic toxicity 55 EOquin 55 #mg dose [001] 55 plasminogen activators 55 HGS ETR1 55 Ph + ALL 55 3TC lamivudine Epivir 55 PROMACTA 55 malignant pleural mesothelioma MPM 55 GPIIb IIIa 55 topoisomerase 55 sapacitabine 55 favorable pharmacokinetic profile 55 treatment regimens 55 alkylating 55 Preclinical studies suggest 55 Privigen 55 ERCC1 55 immunotherapeutic agent 55 levodopa 55 #mg/#mg 55 fluticasone salmeterol 55 olaparib 55 metastatic RCC 55 intraperitoneal chemotherapy 55 locoregional 55 docetaxel prednisone 55 mCRC 55 chemoresistant 55 TRISENOX 55 pegylated alpha interferon 55 elotuzumab 55 baminercept 55 ketorolac 55 imiquimod 55 dose clopidogrel 55 Tavocept 55 BCG refractory 55 rHuEPO 55 peg interferon 55 Voreloxin 55 palifermin 55 PEP# [003] 55 PSADT 55 Combo Stent 55 Tasigna nilotinib 55 cytotoxic therapy 55 vWF 55 antithrombotic 55 Desferal 55 Gleevec imatinib mesylate 55 preoperative chemotherapy 55 Prograf ® 55 interferon beta therapy 55 neostigmine 55 SIR Spheres 55 lansoprazole 55 carmustine 55 Tacrolimus 55 nanomolar 55 beta2 agonist 55 tamsulosin 55 HuMax CD4 55 proteasome inhibitor bortezomib 55 synthetic peptide 55 anti emetic 55 ganetespib 55 olmesartan 55 administered orally 55 ifosfamide 55 anti TNF 55 REYATAZ R 55 mecamylamine 55 TAFA# 55 epoetin alpha 55 captopril 55 ATL# [001] 55 induces apoptosis 55 PLX# 55 leukotriene receptor antagonist 55 comparator PI r 55 Vandetanib 54 MYLOTARG 54 BRIM2 54 pegylated interferon alfa 2b 54 thrombolytics 54 antimetabolite 54 oral levofloxacin 54 active comparator 54 cisplatin resistant 54 ceftazidime 54 systemic antifungal 54 Bicalutamide 54 Sandostatin LAR Depot 54 injected subcutaneously 54 INCB# [002] 54 MNTX 54 regorafenib 54 adalimumab 54 proteasome inhibitors 54 allogeneic SCT 54 eflornithine 54 Linaclotide 54 ZEVALIN 54 sitagliptin 54 gliclazide 54 immunomodulating 54 darbepoetin alfa 54 abciximab 54 menadione 54 efalizumab 54 epoetin 54 GM CSF 54 postoperative chemotherapy 54 non squamous NSCLC 54 mcg kg 54 RoACTEMRA 54 tumor progression TTP 54 vidofludimus 54 latanoprost 54 Arsenic trioxide 54 Traficet EN 54 multiple myeloma MM 54 ONTAK 54 levodopa carbidopa 54 Peginterferon alfa 2b 54 mg kg dose 54 forskolin 54 CVP chemotherapy 54 lenalidomide Revlimid 54 interferon beta 1a 54 DFMO 54 amikacin 54 oral antidiabetic 54 pro apoptotic 54 poloxamer 54 interferon ribavirin 54 TREDAPTIVE 54 Axitinib